Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
5.0%
% of FHLC's 349 holdings also in PPH
66.7%
% of PPH's 27 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 11.9% | 11.3% |
|
JOHNSON & JOHNSON | 6.4% | 6.6% | 6.4% |
|
ABBVIE INC | 6.1% | 6.5% | 6.1% |
|
MERCK & CO. INC. | 3.8% | 4.8% | 3.8% |
|
PFIZER INC | 2.4% | 4.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 7.3% |
|
ABBOTT LABORATORIES | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
AMGEN INC | 2.8% |
|
GILEAD SCIENCES INC | 2.3% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
DANAHER CORP | 2.2% |
|
STRYKER CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
FHLC Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.9% |
 |
SANOFI-AVENTIS-ADR | -4.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | -4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% |
|
CENCORA INC | -4.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.1% |
|
MCKESSON CORP | -3.4% |
|
ZOETIS INC | -3.3% |